Novartis signs $400M takeover deal with biotech firm

Novartis AG announced Wednesday that it will acquire Protez Pharmaceuticals, a biotech firm based in Malvern, Pa., for $400 million. The deal grants Novartis rights to PZ-601, an injectable antibiotic developed by Protez to fight potentially lethal drug-resistant infections, including those caused by MRSA and other superbugs.

View Full Article in:

American City Business Journals · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX